Sensus Healthcare Inc (SRTS) soared 8.25 in the last month: It’s impossible to believe the numbers

Sensus Healthcare Inc (NASDAQ: SRTS) on Monday, soared 8.25% from the previous trading day, before settling in for the closing price of $3.88. Within the past 52 weeks, SRTS’s price has moved between $1.79 and $7.74.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Annual sales at Healthcare sector company grew by 28.03% over the past five years. The company achieved an average annual earnings per share of 275.00%. With a float of $12.89 million, this company’s outstanding shares have now reached $16.37 million.

Sensus Healthcare Inc (SRTS) Insider Updates

Observing investor behavior towards Medical Devices industry stocks is more important than anything else. The insider ownership of Sensus Healthcare Inc is 21.32%, while institutional ownership is 16.14%. The most recent insider transaction that took place on Sep 14, was worth 28,773. In this transaction CHIEF EXECUTIVE OFFICER of this company bought 10,000 shares at a rate of $2.88, taking the stock ownership to the 1,175,293 shares. Before that another transaction happened on Aug 28, when Company’s PRESIDENT AND GENERAL COUNSEL bought 1,000 for $2.99, making the entire transaction worth $2,990. This insider now owns 58,774 shares in total.

Sensus Healthcare Inc (SRTS) Performance Highlights and Predictions

Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.25 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 275.00% per share during the next fiscal year.

Sensus Healthcare Inc (NASDAQ: SRTS) Trading Performance Indicators

Sensus Healthcare Inc (SRTS) is currently performing well based on its current performance indicators. A quick ratio of 8.94 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.82.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.03, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach 0.18 in one year’s time.

Technical Analysis of Sensus Healthcare Inc (SRTS)

Sensus Healthcare Inc (NASDAQ: SRTS) saw its 5-day average volume 0.27 million, a positive change from its year-to-date volume of 0.15 million. As of the previous 9 days, the stock’s Stochastic %D was 86.12%. Additionally, its Average True Range was 0.26.

During the past 100 days, Sensus Healthcare Inc’s (SRTS) raw stochastic average was set at 90.60%, which indicates a significant increase from 82.14% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 59.46% in the past 14 days, which was lower than the 71.21% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $2.80, while its 200-day Moving Average is $2.84. Nevertheless, the first resistance level for the watch stands at $4.41 in the near term. At $4.62, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.79. If the price goes on to break the first support level at $4.03, it is likely to go to the next support level at $3.86. Assuming the price breaks the second support level, the third support level stands at $3.65.

Sensus Healthcare Inc (NASDAQ: SRTS) Key Stats

Market capitalization of the company is 68.80 million based on 16,382K outstanding shares. Right now, sales total 44,530 K and income totals 24,240 K. The company made 3,900 K in profit during its latest quarter, and -1,450 K in sales during its previous quarter.